Asset
BICIFADINE
XTL Biopharmaceuticals Ltd. American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00597649 | phase2 | terminated | 2007-10-01 | 2008-12-01 | XTL Biopharmaceuticals | A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy |
| NCT00553592 | phase2 | unknown | 2007-09-01 | — | XTL Biopharmaceuticals | Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes |
FDA applications (0)
This company has no applications containing this asset.